Press Releases
PARIS, June 3, 2024 /PRNewswire/ -- A spectacular, never-before-seen 30-minute experience will open on the Champs-Élysées on 7 June 2024.
The Théâtre du Lido offers visitors an immersive multi-sensory attraction every day from 11am to 8pm, engulfing them in an artistic vision inspired by the revisited and enhanced music of Vivaldi's Four Seasons.
With climate change, the four distinct seasons are becoming increasingly uncertain. With the help of artificial... (continue reading...)
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 3, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following... (continue reading...)
At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 62% compared to KEYTRUDA alone in these patients
The 2.5-year recurrence-free survival rate of mRNA-4157 (V940) in combination with KEYTRUDA was 74.8% as compared to 55.6% for KEYTRUDA alone, with the benefit observed across exploratory subgroups
The companies have... (continue reading...)
Des Moines, IA, June 03, 2024 (GLOBE NEWSWIRE) -- LCS has announced the finalists for the 2024 LCS “Chef of the Year” competition. The annual competition celebrates the hospitality and culinary talents of chefs in senior living communities owned and managed by Life Care Services. Chef of the Year finalists were selected by a steering committee that reviewed applicant recipes, plated dishes, and videos highlighting work in their respective communities.
Five... (continue reading...)
~ Geoff Birkett, Chief Commercial Officer, Invited to Serve on the Opening Panel at the EPHMRA 2024 Annual Conference ~
SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid misuse, abuse and overdose, today announced that Geoff Birkett, the Company's Chief Commercial Officer,... (continue reading...)
More Press Releases
View Older Stories-
Form 8.3 - Irish Residential Properties REIT plc
-
Genflow Biosciences PLC Announces Notice of AGM
-
Stillwater Critical Minerals Appoints Glencore’s Bradley Adamson to its Board of Directors
-
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
-
GameSquare Sells Non-Core Content Management Software and PR Media Distribution Assets
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Report on transactions of executives and related parties in ROCKWOOL A/S shares
-
Hi-Tech Pharmaceuticals: Increases Capacity on Precision Protein™ Hydrolyzed Whey
-
Eagle Royalties Appoints New Chief Financial Officer
-
Zedge To Report Third Fiscal Quarter 2024 Results
-
Procure Disaster Recovery Strategy ETF (NASDAQ:FIXT) Up 35% Since Launch
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
-
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
-
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
-
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities
-
First Fully Electronic F-TIIE Swap Trade Executed on the Bloomberg SEF
-
Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing Strategy
-
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
-
NorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
DIGITIMES Asia: Nvidia's Jensen Huang discloses next-gen Ruben platform and physical AI vision at NTU keynote
-
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
-
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
-
Molecular Templates, Inc. Provides Interim Update
-
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Aptevo Participating in the BIO International Convention
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
V2X announces successful repricing and extension of Term Loan
-
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
-
Kelley Shaw Joins Alliant Employee Benefits, Will Service Diverse Southeast Client Base
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
TÜV Rheinland's Northeast Technology & Innovation Center receive accreditation to verify equipment to be imported into Korea and other significant accreditations
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
-
U.S.-based Lithium Producer International Battery Metals (IBAT) Names Iris Jancik as CEO to Lead Global Commercial Expansion
-
Teako Minerals Announces Changes to the Board of Directors and Officer Roles
-
Oleg Firer Wins Judgement Against Grenada Government for Unlawful Recall
-
Argo Completes First Phase of MOU with Connective Global, Secures R&D Facility at University Putra Malaysia
-
Ready Capital to Present at Nareit’s REITweek 2024
-
MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
-
PureCycle Provides Update on Ironton Purification Facility
-
Modular Medical Announces Addition to the Russell Microcap(R) Index
-
Gryphon Digital Mining set to join Russell Microcap(R) Index